ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
ADC Therapeutics SA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.44+0.04 (+2.86%)
Close on Oct 19, 2026
- Market cap
- $223.22M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns ADC Therapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 6 sales
Net sold $19.64M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dr. Hans-Peter Wild | 9,788,944 | 9.61% | 13G (passive) amendment | May 15, 2025 |
| W. Lawrence Hawkins | 8,477,338 | 6.80% | 13G (passive) amendment | Dec 31, 2025 |
| Prosight Management, LP | 7,195,374 | 5.80% | 13G (passive) amendment | Sep 30, 2025 |
| BlackRock, Inc. | 6,857,815 | 5.40% | 13G (passive) | Jun 30, 2026 |
| Redmile Group, LLC | 15,666,731 | 14.00% | 13G (passive) amendment | Jun 30, 2025 |
| Jeremy C. Green | 12,717,487 | 9.90% | 13G (passive) amendment | Apr 20, 2026 |
| Wilmot B. Harkey | 12,326,184 | 9.69% | 13G (passive) | Jun 30, 2026 |
| TCG Crossover GP II, LLC | 11,390,175 | 9.20% | 13G (passive) | Oct 27, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ameet Mallik | Chief Executive Officer, Director | 2,790,870 | 2.19% | Jul 2, 2026 |
| Mohamed Zaki | Chief Medical Officer | 896,317 | 0.70% | Jul 2, 2026 |
| Peter J. Graham | Chief Legal Officer | 841,640 | 0.66% | Jul 2, 2026 |
| Jose Carmona | Chief Financial Officer | 938,076 | 0.73% | Jul 2, 2026 |
| Lisa Michelle Kallebo | Chief Accounting Officer | 128,224 | 0.10% | Feb 18, 2026 |
| Viviane Monges | Director | 186,447 | 0.15% | Jun 3, 2026 |
| Victor Sandor | Director | 140,686 | 0.11% | Jun 3, 2026 |
| Robert Azelby | Director | 112,805 | 0.09% | Jun 3, 2026 |
| Timothy Coughlin | Director | 72,400 | 0.06% | Jun 3, 2026 |
| Jean-Pierre Bizzari | Director | 139,302 | 0.11% | Jun 3, 2026 |
| Ron Squarer | Director | 123,431 | 0.10% | Jun 3, 2026 |
| Peter Hug | Director | 263,344 | 0.21% | Jun 3, 2026 |
| Jeremy Green | 10% owner | 28,812,443 | 22.57% | Apr 2, 2026 |
| RedCo II Master Fund, L.P. | 10% owner | 38,233,265 | 29.95% | Apr 2, 2026 |
| Redmile Group, LLC | 10% owner | 27,864,257 | 21.83% | Apr 2, 2026 |
| Thomas Pfisterer | – | 625,755 | 0.49% | May 19, 2025 |
| Hans Peter Wild | 10% owner | 9,788,944 | 7.67% | May 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ameet Mallik Chief Executive Officer, Director | Jun 30, 2026 | Award | +675,000 | – | – | 2,121,769 |
| Peter J. Graham Chief Legal Officer | Jun 30, 2026 | Award | +221,100 | – | – | 841,640 |
| Mohamed Zaki Chief Medical Officer | Jun 30, 2026 | Award | +213,900 | – | – | 896,317 |
| Jose Carmona Chief Financial Officer | Jun 30, 2026 | Award | +203,700 | – | – | 938,076 |
| Timothy Coughlin Director | Jun 3, 2026 | Tax withholding | −12,600 | $3.08 | $38.81K | 72,400 |
| Ron Squarer Director | Jun 3, 2026 | Tax withholding | −15,196 | $3.08 | $46.80K | 123,431 |
| Peter Hug Director | Jun 3, 2026 | Tax withholding | −2,156 | $3.08 | $6.64K | 263,344 |
| Viviane Monges Director | Jun 3, 2026 | Tax withholding | −2,596 | $3.08 | $8.00K | 186,447 |
| Jean-Pierre Bizzari Director | Jun 3, 2026 | Tax withholding | −12,600 | $3.08 | $38.81K | 139,302 |
| Robert Azelby Director | Jun 3, 2026 | Tax withholding | −12,600 | $3.08 | $38.81K | 112,805 |
| Victor Sandor Director | Jun 3, 2026 | Tax withholding | −12,600 | $3.08 | $38.81K | 140,686 |
| Timothy Coughlin Director | Jun 1, 2026 | Award | +45,000 | – | – | 85,000 |
| Ron Squarer Director | Jun 1, 2026 | Award | +45,000 | – | – | 138,627 |
| Peter Hug Director | Jun 1, 2026 | Award | +45,000 | – | – | 265,500 |
| Viviane Monges Director | Jun 1, 2026 | Award | +45,000 | – | – | 189,043 |
| Jean-Pierre Bizzari Director | Jun 1, 2026 | Award | +45,000 | – | – | 151,902 |
| Robert Azelby Director | Jun 1, 2026 | Award | +45,000 | – | – | 125,405 |
| Victor Sandor Director | Jun 1, 2026 | Award | +45,000 | – | – | 153,286 |
| RedCo II Master Fund, L.P. 10% owner | Apr 2, 2026 | Sale | −2,529,491 | $3.28 | $8.30M | 10,265,297 |
| RedCo II Master Fund, L.P. 10% owner | Apr 2, 2026 | Sale | −2,634,506 | $3.28 | $8.64M | 12,666,731 |
| RedCo II Master Fund, L.P. 10% owner | Apr 1, 2026 | Sale | −169,265 | $3.80 | $643.21K | 15,301,237 |
| RedCo II Master Fund, L.P. 10% owner | Apr 1, 2026 | Sale | −162,517 | $3.80 | $617.56K | 12,794,788 |
| RedCo II Master Fund, L.P. 10% owner | Mar 31, 2026 | Sale | −188,407 | $3.75 | $706.53K | 12,957,305 |
| RedCo II Master Fund, L.P. 10% owner | Mar 31, 2026 | Sale | −196,229 | $3.75 | $735.86K | 15,470,502 |
| Lisa Michelle Kallebo Chief Accounting Officer | Feb 13, 2026 | Tax withholding | −5,433 | $3.99 | $21.68K | 128,224 |
| Lisa Michelle Kallebo Chief Accounting Officer | Feb 13, 2026 | Award | +62,900 | $3.99 | $250.97K | 133,657 |
| Jose Carmona Chief Financial Officer | Feb 13, 2026 | Tax withholding | −25,880 | $3.99 | $103.26K | 734,376 |
| Jose Carmona Chief Financial Officer | Feb 13, 2026 | Award | +271,600 | $3.99 | $1.08M | 760,256 |
| Peter J. Graham Chief Legal Officer | Feb 13, 2026 | Tax withholding | −33,294 | $3.99 | $132.84K | 620,540 |
| Peter J. Graham Chief Legal Officer | Feb 13, 2026 | Award | +294,800 | $3.99 | $1.18M | 653,834 |
| Mohamed Zaki Chief Medical Officer | Feb 13, 2026 | Award | +285,200 | $3.99 | $1.14M | 707,020 |
| Mohamed Zaki Chief Medical Officer | Feb 13, 2026 | Tax withholding | −24,603 | $3.99 | $98.17K | 682,417 |
| Ameet Mallik Chief Executive Officer, Director | Feb 13, 2026 | Award | +900,000 | $3.99 | $3.59M | 1,550,000 |
| Ameet Mallik Chief Executive Officer, Director | Feb 13, 2026 | Tax withholding | −103,231 | $3.99 | $411.89K | 1,446,769 |
| Ameet Mallik Chief Executive Officer, Director | Dec 6, 2025 | Tax withholding | −233,146 | $3.29 | $767.05K | 1,319,101 |
| Lisa Michelle Kallebo Chief Accounting Officer | Dec 6, 2025 | Tax withholding | −7,140 | $3.29 | $23.49K | 70,757 |
| Jose Carmona Chief Financial Officer | Dec 6, 2025 | Tax withholding | −53,236 | $3.29 | $175.15K | 488,656 |
| Mohamed Zaki Chief Medical Officer | Dec 6, 2025 | Tax withholding | −41,068 | $3.29 | $135.11K | 421,820 |
| Peter J. Graham Chief Legal Officer | Dec 6, 2025 | Tax withholding | −49,508 | $3.29 | $162.88K | 359,034 |
| Ron Squarer Director | Jun 13, 2025 | Tax withholding | −15,184 | $3.58 | $54.36K | 93,627 |
| Victor Sandor Director | Jun 13, 2025 | Tax withholding | −12,600 | $3.58 | $45.11K | 108,286 |
| Jean-Pierre Bizzari Director | Jun 13, 2025 | Tax withholding | −12,600 | $3.58 | $45.11K | 106,902 |
| Peter Hug Director | Jun 13, 2025 | Tax withholding | −2,144 | $3.58 | $7.68K | 220,500 |
| Viviane Monges Director | Jun 13, 2025 | Tax withholding | −2,584 | $3.58 | $9.25K | 144,043 |
| Robert Azelby Director | Jun 13, 2025 | Tax withholding | −12,600 | $3.58 | $45.11K | 80,405 |
| Viviane Monges Director | Jun 3, 2025 | Award | +40,000 | – | – | 146,627 |
| Victor Sandor Director | Jun 3, 2025 | Award | +40,000 | – | – | 120,886 |
| Peter Hug Director | Jun 3, 2025 | Award | +40,000 | – | – | 222,644 |
| Robert Azelby Director | Jun 3, 2025 | Award | +40,000 | – | – | 93,005 |
| Jean-Pierre Bizzari Director | Jun 3, 2025 | Award | +40,000 | – | – | 119,502 |
| Ron Squarer Director | Jun 3, 2025 | Award | +40,000 | – | – | 108,811 |
| Timothy Coughlin Director | Jun 3, 2025 | Award | +40,000 | – | – | 40,000 |
| Thomas Pfisterer – | May 15, 2025 | Other | −451,856 | – | – | 173,899 |
| Hans Peter Wild 10% owner | May 15, 2025 | Other | +9,788,944 | – | – | 9,788,944 |
| Ameet Mallik Chief Executive Officer, Director | May 6, 2025 | Tax withholding | −26,758 | $1.29 | $34.52K | 1,552,247 |
| Peter J. Graham Chief Legal Officer | Feb 13, 2025 | Award | +220,000 | $1.61 | $354.20K | 408,542 |
| Jose Carmona Chief Financial Officer | Feb 13, 2025 | Award | +240,000 | $1.61 | $386.40K | 541,892 |
| Lisa Michelle Kallebo Chief Accounting Officer | Feb 13, 2025 | Award | +41,900 | $1.61 | $67.46K | 77,897 |
| Ameet Mallik Chief Executive Officer, Director | Feb 13, 2025 | Award | +650,000 | $1.61 | $1.05M | 1,579,005 |
| Mohamed Zaki Chief Medical Officer | Feb 13, 2025 | Award | +230,000 | $1.61 | $370.30K | 462,888 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Sandor Victor Director | Jun 18, 2024 | 6,995 | $20.22K | Jun 17, 2024 | Vesting of Restricted Share Unit Grant |
| Bizzari Jean Director | Jun 18, 2024 | 6,995 | $20.22K | Jun 17, 2024 | Vesting of Restricted Share Unit Grant |
| Squarer Ron Director | Jun 18, 2024 | 6,995 | $20.22K | Jun 17, 2024 | Vesting of Restricted Share Unit Grant |
| Azelby Robert Director | Jun 18, 2024 | 6,995 | $20.22K | Jun 17, 2024 | Vesting of Restricted Share Unit Grant |
| Mallik Ameet Officer and Director | May 7, 2024 | 29,731 | $134.19K | May 7, 2024 | Vesting of Restricted Share Unit Grant |